- Recommendation ID
- IPG638/1
- Question
Further research on electrically stimulated intravesical chemotherapy for nonmuscle-invasive bladder cancer should include randomised controlled trials compared with
standard care, which should report details of patient selection.- Any explanatory notes
(if applicable) Current evidence on electrically stimulated intravesical chemotherapy for nonmuscle-invasive bladder cancer shows there are no major safety concerns. Evidence on efficacy is limited in quantity and quality. Therefore, this procedure should only be used in the context of research.
Source guidance details
- Comes from guidance
- Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer
- Number
- IPG638
- Date issued
- January 2019
Other details
Is this a recommendation for the use of a technology only in the context of research? | Yes |
Is it a recommendation that suggests collection of data or the establishment of a register? | No |
Last Reviewed | 31/01/2019 |